Michaela Hicks, PA
Medical · Frederick, MDNPI 1932695764
Payments from drug & device makers
Across 101 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$355
- AstraZeneca$283
- Takeda Pharmaceuticals U.S.A., Inc.$216
- GSK$206
- Optinose US, Inc.$186
- Sanofi$162
- plus $536 from 10 others
What the payments were for
- Food & beverage$1,944100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $355 |
| AstraZeneca | 17 | $283 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $216 |
| GSK | 17 | $206 |
| Optinose US, Inc. | 8 | $186 |
| Sanofi | 8 | $162 |
| Grifols USA, LLC | 6 | $122 |
| Amgen | 4 | $116 |
| Novartis | 5 | $93 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| CSL Behring | 1 | $35 |
| Pfizer | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $15 |
How this compares
$1,944 in reported general payments places this provider in the 70th percentile of 543 medical providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levocetirizine Dihydrochloride | 19 | $505 |
| Fluticasone Propionate | 12 | $498 |
| Ipratropium Bromide | 12 | $390 |
| Azelastine Hcl | 17 | $275 |
| Famotidine | 15 | $6 |
Paid to pharmacies, not to this prescriber.
Other medical in Frederick
- Kristina TrunnellFrederick$51K
- Sarah JamiesonFrederick$34K
- Evelyn ChavezFrederick$8K
- Collina AfriyieFrederick$7K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.